STATE OF WEST VIRGINIA
FILED
SUPREME COURT OF APPEALS November 12, 2014
RORY L. PERRY II, CLERK
SUPREME COURT OF APPEALS
THEODORE B. STUART, OF WEST VIRGINIA
Claimant Below, Petitioner
vs.) No. 13-1229 (BOR Appeal No. 2048547)
(Claim No. 2009090183)
WEST VIRGINIA DIVISION OF JUVENILE SERVICES,
Employer Below, Respondent
MEMORANDUM DECISION
Petitioner Theodore B. Stuart, by George Zivkovich, his attorney, appeals the decision of
the West Virginia Workers’ Compensation Board of Review. The West Virginia Division of
Juvenile Services, by H. Dill Battle III, its attorney, filed a timely response.
This appeal arises from the Board of Review’s Final Order dated November 22, 2013, in
which the Board affirmed a June 14, 2013, Order of the Workers’ Compensation Office of
Judges. In its Order, the Office of Judges affirmed the claims administrator’s June 8, 2012,
decision denying authorization for a lumbar spine MRI; an EMG of the left lower extremity; and
the medications Vicodin, Neurontin, and Flexeril. The Court has carefully reviewed the records,
written arguments, and appendices contained in the briefs, and the case is mature for
consideration.
This Court has considered the parties’ briefs and the record on appeal. The facts and legal
arguments are adequately presented, and the decisional process would not be significantly aided
by oral argument. Upon consideration of the standard of review, the briefs, and the record
presented, the Court finds no substantial question of law and no prejudicial error. For these
reasons, a memorandum decision is appropriate under Rule 21 of the Rules of Appellate
Procedure.
Mr. Stuart was injured on April 29, 2009, while participating in a form of pressure point
control training. On May 21, 2009, the claims administrator held the claim compensable for
lumbar strain, lumbosacral strain, and sacroiliac strain. Mr. Stuart has a well-documented history
of back problems predating the April 29, 2009, compensable injury. On February 1, 2007, a
lumbar spine MRI revealed mild to moderate degenerative spondylosis with a small annular
fibrosis tear. A second lumbar spine MRI performed on September 29, 2007, revealed
1
degenerative disc disease with a mild bulge and annular tear at L5-S1 without a disc herniation
or spinal stenosis, along with mild facet arthritic changes at the L5-S1 level. Another MRI
performed on May 28, 2009, revealed facet arthritic changes at L4-5 and degenerative disc
disease with a mild bulge and mild facet arthritic changes at L5-S1.
Following the April 29, 2009, injury, Mr. Stuart began treating with Michael
Shramowiat, M.D., who treated him with various medications. Dr. Shramowiat has also made
numerous requests for authorization of diagnostic imaging. Sushil Sethi, M.D., performed an
independent medical evaluation on August 18, 2009. He opined that the compensable soft tissue
injuries had resolved long ago, and further opined that Mr. Stuart’s current treatment is unrelated
to the compensable injuries. On January 15, 2010, Marsha Lee Bailey, M.D., performed an
independent medical evaluation. She opined that Mr. Stuart’s ongoing complaints are solely the
result of degenerative disc disease and degenerative joint disease and are unrelated to the
compensable injuries. She further opined that additional treatment is unnecessary in relation to
the compensable injuries and stated that Mr. Stuart’s ongoing treatment is aimed at treating
degenerative changes unrelated to the compensable injuries.
On October 6, 2011, Rebecca Thaxton, M.D., performed a records review and opined that
the use of the medications Vicodin, Neurontin, and Flexeril should not be authorized in the
instant claim, and noted that the claims administrator is not currently authorizing the use of those
medications. On April 3, 2012, a repeat lumbar spine MRI was performed and revealed a disc
protrusion at L5-S1 with mild facet arthropathy and minimal Grade I retrolisthesis of L5 on S1.
On April 6, 2012, James Dauphin, M.D., performed a physician’s review. He opined that a
request from Dr. Shramowiat for authorization of a lumbar spine MRI; an EMG of the left lower
extremity; and the medications Vicodin, Neurontin, and Flexeril should be denied. Dr. Dauphin
further opined that the requested medications are most likely related to treatment of degenerative
disc disease unrelated to the compensable injury. Finally, he stated that there is no need to repeat
an MRI on a two-year-old uncomplicated lumbar spine sprain.
The claims administrator denied Dr. Shramowiat’s request for authorization of a lumbar
spine MRI; EMG of the left lower extremity; and the medications Vicodin, Neurontin, and
Flexeril on June 8, 2012. On February 9, 2013, Dr. Shramowiat was deposed. He testified that he
requested authorization for a repeat lumbar spine MRI and EMG because Mr. Stuart complained
of persistent leg pain. He further testified that the disc protrusion seen on the April 3, 2012, MRI
could be the result of degenerative changes arising from the 2009 compensable injury. However,
he went on to state that he is not certain that the 2009 compensable injury was severe enough to
cause a progression of Mr. Stuart’s known pre-existing degenerative disc disease.
In its Order affirming the June 8, 2012, claims administrator’s decision, the Office of
Judges held that the preponderance of the evidence does not support the authorization of a
lumbar spine MRI; an EMG of the left lower extremity; and the medications Vicodin, Neurontin,
and Flexeril. Mr. Stuart disputes this finding and asserts that the evidence of record demonstrates
that the requested medical treatment should be authorized.
2
The Office of Judges relied on the opinions of Dr. Thaxton and Dr. Bailey, who
collectively opined that authorization of the requested lumbar spine MRI; EMG of the left lower
extremity; and the medications Vicodin, Neurontin, and Flexeril should be denied. The Office of
Judges also relied on Dr. Sethi’s determination that further treatment is not necessary in relation
to the compensable injury. Additionally, the Office of Judges noted that on August 18, 2011, it
affirmed the claims administrator’s October 16, 2009, denial of Dr. Shramowiat’s request to add
lumbar radiculopathy as a compensable component of the claim. Also on August 18, 2011, the
Office of Judges affirmed February 26, 2010; May 6, 2010; and March 22, 2010, claims
administrator’s decisions denying authorization for a lumbar myelogram, physical therapy, and a
reopening of Mr. Stuart’s claim for further consideration of temporary total disability benefits
based on a finding that Mr. Stuart’s current condition arises from pre-existing degenerative
changes and is unrelated to the 2009 compensable injury. The Board of Review affirmed both
August 18, 2010, Orders of the Office of Judges on January 25, 2013, and this Court affirmed the
Board of Review’s decision on June 11, 2014. Finally, the Office of Judges concluded that the
requested lumbar spine MRI; EMG of the left lower extremity; and the medications Vicodin,
Neurontin, and Flexeril do not constitute reasonable and necessary medical treatment in relation
to the compensable soft tissue injury of April 29, 2009. The Board of Review reached the same
reasoned conclusions in its decision of November 22, 2013. We agree with the reasoning and
conclusions of the Board of Review.
For the foregoing reasons, we find that the decision of the Board of Review is not in clear
violation of any constitutional or statutory provision, nor is it clearly the result of erroneous
conclusions of law, nor is it based upon a material misstatement or mischaracterization of the
evidentiary record. Therefore, the decision of the Board of Review is affirmed.
Affirmed.
ISSUED: November 12, 2014
CONCURRED IN BY:
Chief Justice Robin J. Davis
Justice Brent D. Benjamin
Justice Margaret L. Workman
Justice Menis E. Ketchum
Justice Allen H. Loughry II
3